2018 American Transplant Congress Archives - Page 46 of 211

C1q-Binding Donor-Specific Anti-HLA Antibodies for Clinical Decision Making in Kidney Recipients with Antibody-Mediated Rejection Receiving Standard of Care Treatment

C. Lefaucheur,¹ D. Viglietti,¹ Y. Bouatou,¹ O. Aubert,¹ A. Zeevi,² A. Loupy.¹
C3a Receptor Regulates the CD8 T-Cell Alloresponse via Intrinsic and Extrinsic Mechanisms

J. Horwitz, D. Mathern, P. Heeger.
C4d Staining and Graft Survival in Renal Transplant Recipients

N. Mohiuddin, S. Agarwal, A. Patel, R. Prashar.
C5aR Regulates Myeloid Derived Suppressor Cells (MDSCs) in Transplantation

I. Llaudo, J. Ochando, P. Heeger.
Calcineurin Inhibitors, Macrolides, and the Risk of Adverse Drug Events in Kidney Transplant Recipients

R. Jeong,¹ R. Quinn,² P. Ravani,² K. Lentine,³ A. Lloyd,¹ B. Hemmelgarn,² K. Wen,¹ B. Braam,¹ S. Gourishankar,¹ A. Wong,¹ N. Lam.¹
Calibration of Updated LSAM

J. Pyke,¹ T. Weaver,¹ D. Schladt,¹ N. Salkowski,¹ A. Wey,¹ J. Lake,² W. Kim,³ S. Gentry,⁴ A. Israni.¹
Can Delayed Abdominal Fascia Closure Modify the Short Term Outcome after Adult Liver Transplantation?

I. Vella,¹ M. Pellicciaro,¹ G. Ciancio,² T. Manzia,¹ R. Angelico,³ J. Gaynor,² G. Iaria,¹ G. Tisone,¹ R. Vianna.²
Can Immunosuppression Maintenance after Renal Allograft Failure Prevent Further Sensitization?

A. Mena-Gutierrez, K. Alquadan, A. Santos, K. Womer, M. Casey.
Can We Expect the “Unexpected”?

D. Pinelli, A. Tambur.
Can We Optimise Immunosuppression Strategies in Our Older Renal Transplant Recipients?

M. Morton,¹ K. Parker,¹ C. Morecroft.²
Cancer Incidence after Kidney Transplantation in Saudi Arabia, Comparing Different Induction Agents

H. AlEid, S. Raza, T. Ali, I. Alahmadi, S. Aleid, D. Broering.
Cannabis Dependence or Abuse before and after Kidney Transplantation: Implications for Post-Transplant Outcomes

K. Lentine,¹ T. Alhamad,² N. Lam,³ A. Naik,⁴ F. Koraishy,¹ H. Randall,¹ D. Segev,⁵ V. Dharnidharka,² D. Brennan,⁵ B. Kasiske,⁶ R. Ouseph,¹ M. Schnitzler.¹
Cannabis Use in Liver Transplant Recipients: A Single Center Experience

J. Lee, M. Valadez, E. Moreno, D. Markovic, V. Agopian, J. DiNorcia, H. Yersiz, D. Farmer, R. Busuttil, F. Kaldas.
Cardiac Grafts from Insulin Resistant Donors Trigger a Heightened Immune Response via Excessive Induction of Autophagy

S. Cai,¹ J. Miao,² A. Chandraker.¹
Cardiac MRI May Help to Determine When to Refer Heart Transplant Patients for Redo Heart Transplant

M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Cardiovascular Risk and Subclinical Vascular Damage in Patients after Pediatric Liver Transplantation

H. Wilke,¹ N. Memaran,¹ I. Goldschmidt,¹ B. Borchert-Mörlins,¹ A. von Wick,¹ E. Bauer,¹ R. Blöte,¹ B. Schmidt,² A. Melk.¹
Carfilzomib and Belatacept Reduces DSA and Prolongs Survival in a Highly Sensitized Rhesus Model of Kidney Transplantation

B. Ezekian, J. Kwun, P. Schroder, M. Manook, J. Yoon, M. Mulvihill, K. Freischlag, J. Cochran, K. Kroning, J. Yi, S. Knechtle.
Cause of ESRD is Not Associated with Risk of Post-Transplant CMV Infection

S. Panzer, S. Peery, B. Astor, A. Djamali, T. Singh.
Causes of Death among Deceased Donors

M. Skeans, D. Zaun, B. Kasiske.
CCAAT-Enhancer-Binding Protein Homologous Protein Promotes Liver Ischemia and Reperfusion Injury by Inhibiting Beclin-1-Mediated Autophagy in Hepatocytes

H. Zhou,¹ Z. Rao,¹ Y. Xia,¹ R. Liu,¹ S. Zhou,¹ X. Wang,¹ Y. Zhai,¹ L. Lu.¹
CD19+ Cell Ratio as a Predictive Marker of Antibody Mediated Rejection in ABO Incompatible Kidney Transplantation

K. Unagami,¹ R. Maenosono,² M. Furusawa,² Y. Kakuta,² M. Okumi,² H. Ishida,² K. Tanabe,² K. Nitta.¹
CD4 T Cells Require Both S1PR1 and S1PR4 for Afferent Lymphatic Migration

Y. Xiong,¹ W. Piao,¹ C. Brinkman,¹ L. Li,¹ J. Kulinski,² A. Olivera,² A. Cartier,³ T. Hla,³ S. Schwab,⁴ K. Hippen,⁵ B. Blazar,⁵ J. Bromberg.¹
CD4⁺ T Cells Are Key Barriers to Tolerance Resistance to Islet Allografts in Autoimmune NOD Mice

A. Burrack,¹ K. Beard,² M. Coulombe,² R. Gill.²
CD4⁺CD25^bright Regulatory T Cells Prevent Acute Xenogeneic GVHD

Y. Huang, A. Merchak, H. Xu, A. Chhabra, A. Khalil, Y. Wen, M. Binion, M. Badder, L. Kahn, S. Ildstad.
CD40 Signaling in Proximal Tubules Regulates Fibrosis in Both Hypertension and Chronic Allograft Rejection

V. Bletsos, J. Breidenbach, S. Haller, S. Stepkowski.
CD8-Expressing Transitional B Cells Dominate B Cell Reconstitution in Transplanted Monkeys Receiving Mixed Chimerism Conditioning

K. Pruner, J. Paster, S. Wiebke, O. Jane, H. Isabel, D. Abbas, B. Gilles, M. Joren.
CD8⁺Tissue Resident Memory T Cells Are Key Effector Cells in Intestinal Transplantation Patients with GvHD

O. Aguirre, B. Houlihan, A. Karabala, R. Girlanda, J. Hawksworth, C. Matsumoto, M. Zasloff, T. Fishbein, A. Kroemer.
Cell Free DNA Sequencing for Diagnosing Infections, Estimating Growth Rates, and Characterizing Antibiotic Resistomes in Urine Supernatants

J. Lee,¹ P. Burnham,² D. Dadhania,¹ M. Heyang,² F. Chen,² M. Suthanthiran,¹ I. De Vlaminck.²
Center Variation in Six-Month Post-Donation Follow-Up of Obese Living Kidney Donors

R. Reed,¹ P. MacLennan,¹ B. Shelton,¹ M. Mustian,¹ D. McWilliams,¹ J. Blackburn,² D. Sawinski,³ J. Locke.¹
Central Role of Mef2 Transcription Factors in Regulation of Foxp3 Expression and Treg Function

A. Samanta,¹ L. Wang,¹ R. Han,¹ W. Hancock.^1,2
CFZ533, a New Anti-CD40 mAB Demonstrates Comparable Efficacy and Better Renal Function versus Tacrolimus in De-Novo CNI-Free Kidney Transplantation

B. Nashan,¹ H. Tedesco,¹ M. van den Hoogen,¹ S. Berger,¹ D. Cibrik,¹ S. Mulgaonkar,¹ D. Leeser,¹ R. Alloway,¹ A. Patel,¹ J. Pratschke,¹ C. Sommerer,¹ A. Wiseman,¹ A. van Zuilen,¹ U. Laessing,² J. Rush,² B. Haraldsson,² O. Witzke.¹
Challenges in Cultural and Linguistic Discordance in Caring for Somali Kidney Transplant Recipients at a Large-Volume Transplant Center

K. Peterson,¹ O. Serrano,¹ M. Odegard,¹ S. Mongin,² D. Berglund,³ D. Vock,⁴ S. Chinnakotla,¹ T. Dunn,¹ E. Finger,¹ R. Kandaswamy,¹ T. Pruett,¹ A. Matas.¹
Change in Estimated Glomerular Filtration Rate Pre and Post Development of Donor-Specific Antibodies after Kidney Transplantation

B. Ho,¹ S. Montag,^1,2 H. Bhagat,³ K. Atiemo,¹ A. Daud,¹ R. Kang,¹ L. Zhao,^1,2 J. Schwartz,³ D. Ladner.¹
Change of Bone and Mineral Metabolism in Kidney Donors after Uninephrectomy; Prospective Observational Study

E. Ko,^1,2 H. Cho,^1,3 B. Choi,^1,2 C. Park,^1,2 Y. Kim,^1,2 C. Yang,^1,2 B. Chung.^1,2
Changes in Carotid Arterial Inflammation in De Novo Renal Transplant Recipients as Assessed by ¹⁸F-FDG PET/CT

H. Yoon, Y. Kim, C. Yang, S. Shin.
Changes in Gene Expression of Selected Genes in Patient with Type 1 Diabetes in Peripheral Blood

M. Klak, J. Cichoń, F. Ambrożkiewicz, A. Berman, M. Serwańska-Świętek, M. Wszoła.
Changes in Geographic Disparity Following Share 35

M. Bowring,¹ E. Chow,¹ A. Massie,¹ D. Segev,¹ S. Gentry.^1,2
Changes in Graft Gene Expression Contribute to Coagulopathy in UDCD Liver Transplantation

A. Hessheimer, M. Vendrell, D. Sabater, J. Muñoz, A. Blasi, J. García-Valdecasas, A. Ruíz, M. Navasa, C. Fondevila.
Changes in Phenotype, Immune Suppressive, Function, and Gene Expression of Myeloid Derived Suppressor Cells in Patients Given Combined Kidney and Hematopoietic Cell Transplants in a Tolerance Protocol

K. Jensen,¹ P. Zheng,² J. Xuhuai,² A. Saraswathula,¹ J. Scandling,³ S. Busque,⁴ J. Shizuru,⁵ R. Lowsky,⁵ A. Shori,⁴ H. Maecker,² E. Engleman,¹ E. Meyer,⁵ S. Strober.¹
Changes in Vitamin D Levels after Kidney Transplantation

E. Lum, K. Phonphok, N. Datta, S. Bunnapradist.
Characteristics and Outcomes among Patients with Failed Extubation after Lung Transplantation

L. Smith, R. Kanade, L. Mahan, S. Bollineni, J. Mullins, V. Kaza, M. Mohanka, M. Wait, F. Torres, A. Banga.
Characteristics and Outcomes of Kidney Transplant Recipients with More Than 25 Years of a Functioning Graft

S. Parajuli, D. Mandelbrot, F. Aziz, N. Garg, M. Mohamed, B. Muth, B. Astor, A. Djamali.
Characteristics of Polyomavirus Nephropathy in Renal Transplant Recipient in China: 10 Year Experience

G. Huang, X. Chen, L. Chen.
Characterization of Mycobacterium Tuberculosis Memory T Cell Subsets in Solid Organ Transplant Recipients with Previously Treated Active Tuberculosis

S. Nellimarla, Y. Natori, V. Ferreira, S. Husain, A. Humar, D. Kumar.
Characterization of Exosomal DNA from Human Lung Transplant Recipients

S. Bansal, M. Sharma, R. Walia, R. Bremner, M. Smith, T. Mohanakumar.
Characterization of Mesenchymal Stem Cell Phenotype and Its Immunomodulatory Effects during Allo-Specific T Cell Immune-Responses

Q. Gao, A. Kirk, H. Xu.
Characterization of Renal Allograft Tolerance Induction via Transient Mixed Chimerism in Non-Human Primates

H. Sasaki,¹ C. Thaiss,¹ T. Oura,¹ A. Rosales,² R. Smith,² R. Colvin,² B. Cosimi,¹ T. Kawai.¹
Characterization of Viral and Host Cell Genomic Alterations in EBV+ PTLD

Y. Balachandran,¹ M. McPherson,¹ S. Boyd,² C. Esquivel,¹ S. Krams,¹ O. Martinez.¹
Chronic Antibody Mediated Rejection in Renal Allografts Shows RNA Transcript Patterns That Evolve with Stage

A. Rosales,¹ B. Adam,² M. Mengel,² T. Oura,¹ M. Matsunami,¹ T. Kawai,¹ A. Cosimi,¹ R. Smith,¹ R. Colvin.¹
Chronic Changes on Time Zero Living Donor Allograft Biopsy Portraits Worse Donor Renal Function

A. Nishio-Lucar,¹ J. Murphy,² A. Sites,³ H. Cathro,² A. Doyle,¹ K. Warburton,¹ A. Agarwal.⁴
Chronic Narcotic Use Increases Mortality Rates in Heart Transplantation

G. St. John, T. Chamogeorgakis, H. Nemeh, C. Tita, Y. Selektor, D. Lanfear, C. Williams.
Chronic Rejection: Risk Factors, Clinical Presentation and Outcome in Pediatric Liver Transplant Recipients: A Single Center Experience

T. Miloh, A. Cheng, D. Schady, R. Himes, K. Mysore, K. Hosek, J. Goss.
Ciprofloxacin for BK Viremia Prophylaxis in Kidney Transplant Recipients: Results of a Prospective, Randomized Controlled Trial

S. Patel, S. Kuten, R. Knight, J. Nolte, D. Nguyen, E. Graviss, L. Moore, I. Agboli, C. Pham, A. Gaber.
Circulating Exosomes with Lung Self-Antigens, Kα1Tubulin and Collagen V, and Immune Regulatory Proteins in Lung Transplant Recipient with Primary Graft Dysfunction

M. Sharma, S. Biswas Roy, R. Walia, A. Omar, R. Bremner, M. Smith, T. Mohanakumar.
Circulating Exosomes with Lung Self-Antigens, Kα1Tubulin and Collagen V, and Immunoregulatory Molecules Are Present in Bronchiolitis Obliterans Syndrome Following Pediatric Lung Transplantation

M. Sharma,¹ L. Danziger-Isakov,² P. Heeger,³ S. Sweet,⁴ T. Mohanakumar.¹
Circulating Follicular Helper T Cells (cTfh) in Renal Transplantation: Utility as Rejection Biomarker

R. Laguna-Goya,¹ A. Utrero-Rico,¹ F. Cano-Romero,¹ E. Gómez-Massa,² D. Arroyo,¹ P. Auñon-Rubio,³ A. Sevillano-Prieto,³ M. Castro-Panete,² A. Andrés,³ E. Paz-Artal.^1,2
Circulating T Follicular Helper Cells Expand Following Transplantation and Exhibit a CD44^hi Phenotype That Correlates with Peak Germinal Center Alloreactivity

G. La Muraglia II, M. Wagener, M. Ford, R. Badell.
Circulating Wnt Pathway Factors Are Non-Invasive Biomarkers of Transplant Vascular Injury

M. Seifert,¹ A. Malone,² L. Boohaker,¹ J. Gaut,² S. Jain,² D. Brennan,^2,3 R. Mannon.¹
Class II Anti-HLA IgG2 and IgG3 DSAs Predict Poorer Outcomes in Chronic Antibody Mediated Rejection of Renal Allografts

A. Gueret-Wardle,¹ G. Lucisano,¹ S. Hassan,¹ P. Brookes,² E. Santos-Nunez,² D. Goodall,¹ C. Clarke,¹ J. Galliford,¹ M. Willicombe,¹ D. Taube.¹
Clinical Analysis of Impact of Intraoperative Hepatic Blood Inflow on Acute Kidney Injury Following Allogeneic Liver Transplantation

J. Zhang, Q. Liu, X. Li, Y. Meng, L. Yang, C. Zhang, N. Sun, A. Jiao, J. Lin.
Clinical and Pathological Findings in Hepatitis C Positive Renal Transplant Recipients Following Alemtuzumab Induction

S. Jonchhe, J. Husson, A. Haririan, B. Ravichandran.
Clinical Application of Mesenchymal Stromal Cells with a Simplified Protocol for ABO Incompatible Liver Transplantation in Severe Hepatic Failure Patients

Y. Zhang,^1,2 J. Zheng,^1,2 J. Cai,^1,2 J. Zhang,^1,2 K. Zeng,^1,2 J. Yao,^1,2 Y. Yang.^1,2
Clinical Heterogeneity of Early Anamnestic Donor Specific Antibody Responses in Kidney Transplantation

A. Loethen,¹ A. Lichvar,¹ S. Tremblay,¹ A. Shields,^1,2 A. Dao,¹ M. Cardi,² P. Brailey,¹ A. Girnita,¹ B. Abu Jawdeh,¹ R. Alloway,¹ E. Woodle.¹
Clinical Impact of Antecedent Bariatric Surgery on Liver Transplant Outcomes: A Retrospective Matched Case-Control Study

O. Serrano,¹ K. Peterson,¹ D. Vock,² D. Berglund,¹ R. Kandaswamy,¹ J. Lake,³ T. Pruett,¹ S. Chinnakotla.¹
Clinical Impact of Denovo or Recurrent Donor Specific Antibodies in the First Year Post Kidney Transplant in Patients on Early Steroid Withdrawal Immunosupression Regimen

O. Adebiyi, T. Taber, W. Goggins, D. Mishler, M. Yaqub, A. Sharfuddin.
Clinical Impacts of Deceased Donor Oxygenation Status in Liver Transplant

T. Okamoto,² K. Sasaki,³ H. Niikawa,² M. Fujiki,³ C. Quintini,³ K. Hashimoto,³ C. Miller,³ K. Abu-Elmagd,¹ K. McCurry,² J. Fung.⁴
Clinical Implications of Positive Crossmatch in Liver Retransplants

F. Paterno, S. Tremblay, K. Wima, M. Cuffy, T. Diwan, N. Anwar, E. Woodle, S. Shah.
Clinical Outcomes of Conversion from Calcineurin Inhibitor to Belatacept-Based Immunosuppression in Highly Sensitized Kidney Transplant Recipients

S. Sethi, J. Choi, A. Vo, A. Peng, K. Lim, R. Najjar, S. Jordan, E. Huang.
Clinical Outcomes of HIV-Infected Kidney Transplant Recipients Managed with an Early Corticosteroid Withdrawal Protocol

A. Al Jurdi, E. Liu, M. Aull, M. Lubetsky, D. Serur, S. Kapur, T. Muthukumar.
Clinical Outcomes of Kidney Transplant Recipients Infected with Hepatitis C Virus and Treated with Direct-Acting Antiviral Therapy

M. Alkadi,¹ E. Abuhelaiqa,¹ M. Derbala,² O. Fituri,¹ J. Mahmoud,³ M. Jarman,³ M. Asim,¹ A. Aziz,¹ A. Nauman,¹ A. Hamdi,¹ Y. Medhat,² S. Al Kaabi,² H. Al-Malki.¹
Clinical Outcomes of Late Conversion to Once-Daily Tacrolimus after Liver Transplant

D. Kim,¹ Y. Jung,¹ J. Lee,¹ J. Lee,¹ S. Kim,² M. Ju,¹ M. Kim,¹ S. Kim,¹ D. Joo.¹
Clinical Outcomes of Patients with BK Viremia in ABO-Incompatible Kidney Transplantation and Comparison with ABO-Compatible Kidney Transplantation

J. Yoon, C. Baek, S-.K. Park, H. Kim.
Clinical Outcomes, Care Needs and Adherence in Long Term Intestine Transplant Survivors ≥10 yrs

B. Kosmach-Park,¹ G. Mazariegos.²
Clinical Response to Salvage Bortezomib Therapy for Antibody Mediated Rejection and Mixed Acute Rejection in a High Immunologic Risk Renal Transplant Population

A. Lichvar, J. Benken, E. Benedetti.
Clinical Significance and Therapeutic Potential of Orosomucoid 1 for Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients

H. Higuchi,^1,2 K. Hotta,¹ D. Iwami,¹ J-.J. Jiang,² D. Kamimura,² Y. Arima,² T. Atsumi,² Y. Takada,^1,2 H. Harada,³ M. Murakami,² N. Shinohara.¹
Clinical Significance of BK Virus-Specific ELISPOT Assay in Kidney Transplant Recipients

J. Chang,^1,2 H. Bae,³ K. Park,³ H. Lee,³ B. Choi,^1,2 C. Park,^1,2 C. Yang,^1,2 Y. Kim,^1,2 E-.J. Oh,^1,4 B. Chung.^1,2
Clinical Significance of Isolated v-Lesions in Kidney Transplantation

A. Georgalis,¹ C. Wehmeier,¹ P. Hirt-Minkowski,¹ G. Hönger,¹ H. Hopfer,² J. Steiger,¹ S. Schaub,¹ P. Amico.¹
Clinical Significance of Microvascular Inflammation in the Absence of Anti-HLA DSA in Kidney Transplantation

S. Parajuli, R. Redfield, F. Aziz, N. Garg, M. Mohamed, W. Zhong, T. Ellis, A. Djamali, D. Mandelbrot.
Clinical Significance of Tacrolimus Trough Level at the Early Period after Kidney Transplantation

W. Park,^1,2 S. Yeo,¹ S. Kang,^1,2 H. Park,¹ K. Jin,^1,2 S. Park,^1,2 S. Han.^1,2
Clinical Trials and Electronic Health Records

J. Chen, S. Bhattachrya, M. Sirota, M. Sarwal, A. Butte.
Clinical Utility and Interpretation of CKD Stages in Living Kidney Donors

A. Massie,¹ M. Henderson,¹ F. Al Ammary,¹ J. Snyder,² D. Segev.¹
Clinical Utility of CMV-Specific CD8+ T-Cell Immune Competence Score in Lung and Heart-Lung Transplant Recipients at Risk of Cytomegalovirus Infection

A. Meesing,¹ R. Abraham,² R. Razonable.¹
Clinical Validation of a Novel ELISpot-Based In Vitro Diagnostic Assay to Monitor CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients

B. Banas,¹ D. Steubl,² L. Renders,² D. Chittka,¹ M. Banas,¹ T. Wekerle,³ M. Koch,⁴ O. Witzke,⁵ A. Muehlfeld,⁶ C. Sommerer,⁷ A. Habicht,⁸ C. Hugo,⁹ T. Huenig,¹⁰ M. Lindemann,⁵ T. Schmidt,¹¹ A. Rascle,¹¹ S. Barabas,¹¹ L. Deml,¹¹ R. Wagner,^1,11 B. Kraemer,¹² B. Krueger.¹²
Clinically Relevant Variation of Donor-Derived Cell-Free DNA during Longitudinal Surveillance of Renal Allografts

M. Narayanan,¹ T. Alhamad,² D. Hiller,³ J. Yee,³ R. Woodward,³ J. Bromberg.⁴
Closing Pandora's Box: An Evidence Based Approach to Opioid-Tolerant Patients Following Transplantation. The Case for IV Methadone

A. Aljassem, L. Hall, S. Cohn, D. Bedi, M. Alsibae, K. Putchakayala, S. Tasleem, D. Samarapungavan, C. Carpenter, A. Koffron.
Clostridium Difficile Infection after Liver Transplant is Associated with Poor Long-Term Survival

A. Ahearn, P. Mahboub, N. Theodoropoulos, B. Movahedi, P. Martins, M. Campion, R. Nathan, A. Bozorgzadeh.
CMV and BKV Infections after Kidney Transplantation: Combined Tacrolimus/everolimus Strategy Using Antithymocyte Globulin Induction

T. Jouve,^1,4 R. Germi,^2,4 B. Janbon,¹ G. Fiard,^3,4 P. Malvezzi,¹ L. Rostaing.^1,4
CMV Mismatch Still Negatively Affects Patient and Graft Survival in the Era of CMV Prophylactic and Preemptive Therapy: A Paired Kidney Analysis

N. Leeaphorn,¹ N. Garg,² N. Thamcharoen,¹ E. Khankin,¹ F. Cardarelli,¹ M. Pavlakis.¹
CMV Viremia and Development of CMV-Specific Cytotoxic T-Cells (CMV-Tc) in Pediatric Renal Transplant Recipients

H. Pizzo, B. Shin, M. Toyoda, S. Jordan, D. Puliyanda.
CMV-Specific CD8+ T-Cell Immune Competence Score as Predictor of Outcome for CMV Infection after Transplantation

A. Meesing,¹ R. Abraham,² R. Razonable.¹
CMV-Specific Cell-Mediated Immunity after Valgancyclovir Prophylaxis Predicts Late Onset CMV Infection in Kidney Transplant Patients

M. Jarque,¹ E. Crespo,¹ E. Melilli,² A. Manonelles,² N. Montero,² S. Luque,¹ J. Cruzado,^1,2 J. Grinyo,^1,2 O. Bestard.^1,2
Cognition after Belatacept Conversion

C. Ogbejesi, E. Cohen, K. Belfield, W. Asch.
Cognition and Self-Management in Liver Transplant Recipients

D. Ko,¹ L. Bratzke,² R. Muehrer.²
Cognitive Function and Health Literacy Assessment Outcomes in the First Months after Renal Transplant in a Diverse Single Center Population

J. Trofe-Clark,^1,2 W. Gbemudu,¹ S. Hamel,¹ J. Shults,¹ R. Neubauer,² S. Ryan,¹ M. Kaminski,¹ D. Sawinski,² S. Goral,² M. Bleicher,² M. Lim,² R. Bloom,² P. Reese.²
Cognitive Impairment and Graft Loss in Kidney Transplant Recipients

A. Thomas,¹ J. Ruck,¹ A. Shaffer,¹ C. Haugen,¹ H. Ying,¹ F. Warsame,¹ N. Chu,¹ M. Carlson,¹ A. Gross,¹ S. Norman,² D. Segev,¹ M. McAdams-DeMarco.¹
Cognitive Impairment Influences Transplant Eligibility

A. Gupta, J. Klein, J. Mahnken, R. Montgomery, A. Ilahe, P. Budhiraja, T. Thomas, T. Schmitt, J. Burns, D. Cibrik.
Cold Ischemia Time is an Important Risk Factor for Post-Liver Transplant Prolonged Length of Stay

E. Pan, D. Yoeli, N. Galvan, M. Kueht, R. Cotton, C. O'Mahony, J. Goss, A. Rana.
Cold Pulsatile Machine Perfusion versus Static Cold Storage in Kidneys from Donation after Circulatory Death: A Multi-Centre Randomised Controlled Trial

D. Summers,^1,2 L. Randle,¹ A-.M. O'Sullivan,³ R. Johnson,² D. Collett,² M. Attia,⁴ N. Ahmad,⁴ M. Clancy,⁵ M. Akyol,⁶ A. Tavakoli,⁷ N. Jamieson,³ A. Bradley,¹ C. Watson.¹
Colistin (COL) in Solid Organ Transplant Recipients (SOTR): Friend or Foe?

K. Neyra, C. Huauya Leuyacc, C. Kovacs, V. Athans, E. Cober.
Combination Proteasome Inhibition and Anti-BAFF Therapy Permits Highly Sensitized Rhesus Kidney Transplantation

B. Ezekian, J. Kwun, M. Manook, P. Schroder, J. Yoon, M. Mulvihill, K. Freischlag, J. Park, J. Cochran, K. Kroning, J. Yi, S. Knechtle.
Combined Heart–Kidney Compared to Isolated Heart Transplant in Patients with Chronic Kidney Disease – A Single Center Experience

D. Gauvin, A. Bhalla, W. McCallum, A. Vest, N. Goyal.
Comparative Analysis of Alloantigen-Stimulated Gene Expression in HIV(+) Liver Transplant Rejectors versus Non-Rejectors

S. Chu, K. Lee, C. Ward, P. Stock, Q. Tang.
Comparative Analysis of Bone Marrow versus Blood Monocyte-Derived Regulatory Dendritic Cells for Evaluation in a Miniature Swine Vascular Composite Allotransplantation Model

T. Elgendy,¹ D. Kim,² A. Zahorchak,¹ M. Ezzelarab,¹ M. Solari,² A. Thomson.¹
Comparative Cost Analysis of ABO-Incompatible Living Kidney Transplantation

Y. Kakuta,¹ M. Okumi,¹ K. Unagami,² M. Furusawa,¹ H. Ishida,¹ K. Tanabe.¹
Comparing Outcomes between Induction Immunosuppressive Therapies in Simultaneous Heart/Kidney Transplantation

I. Moinuddin, J. Yu, L. Kang, C. Bhati, D. Bandyopadhyay, A. King, D. Kumar, L. Kamal, D. Tang, I. Yakubu, G. Gupta.
Comparing Outcomes between Induction Immunosuppressive Therapies in Simultaneous Liver/Kidney Transplantation

U. Gautam, T. Reichman, J. Yu, S. Koppu, D. Bandyopadhyay, M. Levy, G. Gupta, L. Kamal.
Comparison of BMI, Waist Circumference and Waist-to-Height Ratio for Identification of Cardiovascular Risk in Pediatric Kidney Transplant Recipients

K. Sgambat, S. Clauss, A. Moudgil.
Comparison of Bortezomib in Addition to Rituximab Based Treatment of Acute Antibody Mediated Rejection in Kidney Transplantation

A. Mattiazzi,^1,2 J. Pagan,^1,2 A. Arunachalam,¹ I. De la Cruz Alcantara,¹ J. Revollo,² A. Centeno,² A. Valdes,^1,2 G. Guerra.^1,2
Comparison of C1Q Binding and Flow Cytometric Crossmatch Results Provides an Accurate Evaluation of Hypersensitive Kidney Transplant Patients

E. Eksioğlu-Demiralp,¹ A. Türkmen,² B. Yelken,² S. Görçin,² O. Elbasi,¹ F. Yalçin,³ B. Koçak,² C. Karatas,⁴ M. Tuncer,⁴ M. Altinel.³
Comparison of Continuous Normothermic Ex Vivo Kidney Perfusion to Hypothermic Preservation Methods in Pig Kidneys Donated after Cardiac Death

M. Hamar,^1,2 P. Urbanellis,¹ D. Kollmann,¹ I. Linares,¹ M. Kaths,¹ D. Bagli,³ A. Konvalinka,⁴ I. Mucsi,¹ A. Ghanekar,¹ L. Robinson,² M. Selzner.¹
Comparison of De Novo Rapamune versus Everolimus Maintenance Immunosuppression; an Interim Analysis

R. Pelletier, A. Rajab, M. Henry, G. Bumgardner.
Comparison of Glycemic Control in Type 1 and Type 2 Diabetic Patients after Pancreas Transplantation

O. Andacoglu,¹ A. Murthy,² J. Ahn,³ J. Verbesey,¹ S. Ghasemian,¹ M. Cooper,¹ P. Abrams.¹
Comparison of Induction and Maintenance Immunosuppression Regimens in Intestinal and Multivisceral Transplantation: An Analysis of the UNOS Registry

S. Nagai,¹ M. Rizzari,¹ Y. Muszkat,² K. Collins,¹ A. Yoshida,¹ S-.M. Jafri,² M. Abouljoud.¹
Comparison of Low Dose and Very Low Dose Extended-Release Tacrolimus / MMF in De Novo Kidney Transplant Recipients- 3 Years Follow-Up

S. Narumi,¹ Y. Watarai,¹ N. Goto,² T. Hiramitsu,¹ M. Tsujita,² M. Okada,¹ K. Futamura,² T. Kobayashi.³
Comparison of Microvascular Inflammation in Renal Allograft Tissue between ABO Incompatible and ABO Compatible Kidney Transplantation

E. Ko,^1,2 B. Choi,^1,2 C. Park,^1,2 Y. Kim,^1,2 C. Yang,^1,2 B. Chung.^1,2
Comparison of No Kasai Portoenterstomy to Failed Kasai: Analysis of UNOS Database

T. Miloh, K. Hosek, S. Harpavath.
Comparison of Outcome in Liver Transplant Patients with Renal Insufficiency and Intraoperative CVVH

J. Gosnell, M. Safwan, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai.
Comparison of Outcomes in African-American and White Primary Kidney Transplant Recipients: A Matched-Pair Analysis

F. Tedla, A. Brar, D. John, N. Sumrani, R. Gruessner, A. Gruessner, M. Salifu.
Comparison of Pure Laparoscopic vs Open Living Donor Right Hepatectomy

B. Lee, Y. Choi, H. Han, Y. Yoon, J. Cho.
Comparison of Recipients with Early and Late Presenting Polyomavirus Nephropathy (PVN) with Regard to Histological Findings and Graft Survival: What is the Influence of CD4/CD8 Ratio on the Presenting Time of PVN

B. Ozdemir,¹ S. Ayva,¹ A. Terzi,¹ A. Ok Atilgan,¹ E. Akcay,¹ E. Ayvazoglu Soy,² F. Ozdemir,³ M. Haberal.²
Comparison of Temperatures for Optimal Preservation of Donor Kidneys during Oxygenated Pulsatile Perfusion

R. Bhattacharjee,¹ M. Richard-Mohamed,² A. Ruthirakanthan,³ R. Mayer,² S. Luke,³ H. Sharma,² M. TunAbraham,² B. Alharbi,² A. Haig,² P. Luke.^1,2,3
Comparison of Three Approaches for Laparoscopic Donor Nephrectomy: Transvaginal, Transumbilical Single Site and Retroperitoneal

M. Miura, H. Higashiyama.
Comparison of Tobacco Consumption versus Marijuana Consumption in Liver Transplant Recipients

P. Serrano Rodriguez, R. Watkins, L. Jurgevich, D. Gerber, A. Nayyar, J. Jadi, C. Moses, C. Desai.
Compatible Donor and Recipient Pairs' Perspectives on Participation in Kidney Paired Donation Programs: The Emotional Implications of Indirect Donation and Transplantation

M. Fortin,¹ J. Gill,² F. Ballesteros,¹ J. Gill.²
Competing Risk Analysis in Renal Allograft Survival: A New Perspective to an Old Problem

M. El ters,¹ B. Smith,² F. Cosio,¹ W. Kremers.²
Complement Activating HLA Class 2 Antibodies Are Associated with Poor Renal Allograft Survival; Multicentre Study

A. Babu,^1,2 O. Shaw,⁵ N. Khovanova,² S. Griffin,⁴ D. Briggs,⁶ N. Krishnan,¹ S. Fletcher,¹ C. Imray,¹ A. Seitz,³ R. Baker,³ M. Wellberry-Smith,³ B. Clarke,³ K. Cullen,³ F. Edwards,⁴ T. Rees,⁴ E. Burrows,⁴ L. Howe,⁵ R. Vaughan,⁵ N. Kessaris,⁷ N. Mamode,⁷ A. Dorling,⁷ D. Zehnder,¹ R. Higgins,^1,2 D. Mitchell,² S. Daga.^2,3
Complement Fixing Donor-Specific Antibodies Are Associated with Increased Risk of Chronic Lung Allograft Dysfunction after Lung Transplantation

C. Ensor,¹ C. Iasella,¹ M. Mangiola,¹ M. Marrari,¹ M. Morrell,¹ N. Shigemura,² J. DCunha,¹ J. McDyer,¹ A. Zeevi.¹
Complex Combined Thoracic/liver Transplant: A Seven Year Experience

N. Presser, J. DiNorcia, V. Agopian, H. Yersiz, D. Farmer, R. Busuttil, F. Kaldas.
Complications and QoL after Living Donor Hepatectomy: Analysis of 176 Cases at a Single Center

S. Chinnakotla, V. Kirchner, S. Mongin, D. Berglund, O. Serrano, T. Pruett.
Components of Microvascular Inflammation (MVI) in Kidney Transplant Biopsies (KTxBX) Impacting Late Death Censored Graft Failure (DCGF)

J. Grande,¹ L. Hunsicker,² R. LeDuc,³ A. Matas,³ The DeKAF Consortium.
Comprehensive Assessment of NSAID Use and Potential Nephrotoxicity Risk in Adult Veteran Kidney Transplant Recipients

J. Chiasson, C. Fominaya, M. Gebregziabher, D. Taber.
Comprehensive Efficacy Analysis of Pancreas Transplantation Alone for Type 1 Diabetes Mellitus

Y. Kudva,¹ V. Dadlani,¹ B. Smith,³ K. Bebjakova,¹ P. Dean,² M. Stegall.²
Comprehensive Validation of Different Clinical Prediction Models on Short- and Long-Term Outcome Following Orthotopic Liver Transplantation

J. Boecker,¹ Z. Czigany,¹ J. Bednarsch,¹ I. Amygdalos,¹ F. Meister,¹ D. Morales Santana,¹ W. Schoening,¹ T. Ulmer,¹ M. Krebbers,¹ G. Koek,¹ D. Kroy,² F. Tacke,² C. Trautwein,² U. Neumann,¹ G. Lurje.¹
Confirmation of the Feasibility of Ex Vivo Creation of a Novel Human Multi-Chimeric Cells Therapy for Tolerance Induction in Vascularized Composite Allotransplantation

J. Cwykiel, G. Rafidi, M. Siemionow.
Congestive Hepatic Fibrosis: Correlation with Cardiac Hemodynamics and Changes after VAD or Cardiac Transplant

S. Dhingra,¹ A. Segura,³ N. Cortes-Santiago,¹ M. Schwartz,⁵ S. Mittal,⁴ P. Jalal,² G. Sood.²
Consequences of Being Listed at a Small Pancreas Program

S. Niederhaus,¹ M. Curry,² A. Fox,² J. Fridell,³ J. Odorico.⁴
Consistency of DCD Procurement Procedures across Organ Procurement Organizations – Preliminary Findings

G. Mitro,¹ A. Ortiz,² R. Warnock,³ P. Wiederhold,³ K. Jiles,³ J. Ortiz.¹
Containment of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections at a Solid Organ Transplant Centre

A. Mularoni,¹ G. Martucci,¹ S. Gruttadauria,¹ M. Campanella,¹ F. Tuzzolino,¹ G. Arena,¹ A. Arcadipane,¹ U. Palazzo,¹ A. Luca,¹ B. Gridelli,¹ P. Grossi.²
Contemporary Desensitization with Low Dose Rituximab Ensures Kidney Transplant Outcome beyond ABO Blood Type Incompatibility:A Comparison between past Regimens in Single Institute

H. Harada, Y. Wada, A. Mitsuke, T. Hirose, N. Fukuzawa, T. Seki.
Contemporary Practice Patterns & Outcomes after Transjugular Intrahepatic Portosystemic Shunt (TIPS) Placement: A Multicenter US Experience of 1,146 Patients

J. Boike,¹ J. Ge,⁵ M. German,³ N. Jest,² G. Morelli,² E. Spengler,³ A. Said,³ A. Lee,³ A. Hristov,³ K. Kolli,⁴ J. Lai,⁴ A. Desai,⁵ S. Junna,⁵ B. Pokhrel,⁵ T. Couri,⁶ S. Paul,⁶ N. Christian-Miller,⁷ C. Frenette,⁷ M. Laurito,⁸ E. Verna,⁸ U. Rahim,⁹ A. Goel,⁹ A. Das,¹ S. Pine,¹ D. Gregory,¹ L. VanWagner.¹
Continuous and Single-Shot Transverse Abdominis Plane (TAP) Block vs. Conventional Analgesia after Kidney Transplant Surgery

J. Sageshima, C. Troppmann, C. Santhanakrishnan, J. McVicar, R. Perez.
Contribution of mTOR Signaling to the β-Catenin Pathway in Regulatory T Cells

F. Marti, L. Turcios, A. Mohamed, M. Mitov, D. Butterfield, R. Gedaly.
Conversion from Twice Daily Immediate Release Tacrolimus to Once Daily Extended Release Tacrolimus (LCP-Tacro) in High Risk Kidney Transplant Recipients

M. Benincasa,¹ V. Colomy,¹ N. Sifontis,¹ S. Rao,² K. Lau,³ S. Karhadkar,³ A. Di Carlo,³ A. Diamond.⁴
Conversion to Mizoribine with Mycophenolate Eliminates or Reduces the BK Virus Load in Kidney Transplant Recipients: A Prospective Study

X-.P. Yuan, C-.B. Chen, Y. Zheng, J. Zhou, C. Wang, X. He.
Corner-Saving Renal Artery Anastomosis for Renal Transplantation

A. Akdur,¹ M. Kus,² G. Moray,¹ S. Yildirim,¹ F. Yarbug Karakayali,³ K. Caliskan,² M. Haberal.¹
Correlation of Kidney Transplant Human Leukocyte Antigen Eplet Mismatching to De Novo Donor Specific Antibody Production and Post-Transplant Outcomes

R. Samudralwar,¹ K. Szempruch,¹ C. Reuter,³ B. Franz,⁴ R. Lee,¹ E. Weimer,⁴ R. Detwiler,² T. Kozlowski,² J. Schmitz.⁴
Cost Analysis of Biliary Strictures Following Orthotopic Liver Transplantation in the United States

J. Jones,¹ N. Bhutiani,¹ D. Wei,² L. Goldstein,³ R. Martin,¹ C. Jones,¹ R. Cannon.¹
Cost Analysis of Loco-Regional Bridging Therapy for Hepatocellular Carcinoma: A National Study

M. Nazzal,¹ R. Ouseph,¹ X. Huiling,¹ M. Schnitzler,¹ C. Varma,¹ H. Randall,¹ J. Tuttle-Newhall,² D. Axelrod,³ K. Lentine.¹
Cost Effectiveness of Hepatitis C Positive Donor Kidney Transplantation for Hepatitis C Negative Recipients with Concomitant Direct-Acting Anti-Viral Therapy

G. Gupta, Y. Zhang, H. Kale, N. Carroll, R. Sterling.
Cost Effectiveness of Lifelong Medicare Immunosuppressant Drug Coverage for Kidney Transplant Recipients in the Current Era

M. Kadatz,¹ J. Gill,² J. Gill,² K. Scott.³
Cost Impacts of Alternative Kidney Transplant Immunosuppression: A National Cohort Study

K. Lentine,¹ D. Axelrod,² V. Dharnidharka,³ H. Xiao,¹ D. Brennan,⁴ D. Segev,⁴ H. Randall,¹ R. Ouseph,¹ A. Naik,⁵ N. Lam,⁶ T. Alhamad,³ B. Kasiske,⁷ G. Hess,⁸ M. Schnitzler.¹
Creatinine Monitoring by Remote Blood Spot Testing in Pediatric Kidney Transplant Recipients

J. Dickerson,¹ K. Jacot,² M. Sinkey,² J. Smith.³
Critical Care Management of Organ Donors with Uncertain Consent Status

M. Varma, J. LaRosa.
Cryptococcal Infections in Kidney Transplant Recipients. A Single Center Experience

M. Radisic,¹ N. Pujato,¹ A. Dotta,² R. Livia Franzini,² M. Bravo,¹ L. Rodriguez Rilo,¹ C. Giampieri,² L. Leon,¹ M. Rial,¹ D. Casadei.¹
CT Based Anthropometric Visceral Fat Measures Predict Complexity, Complications and Low Clearance in Living Donor Nephrectomy

Z. Ahmed,¹ D. Bordom,¹ J. Brown,¹ B. Ridley,¹ R. Uwechue,¹ P. Chandak,¹ N. Kessaris,¹ N. Kurunanithy,² N. Mamode.¹
CTLA4-Ig and Bortezomib Successfully Reverses Established DSA Responses in Allograft-Sensitized Recipients

D. Jain,¹ J. Young,¹ D. Yin,¹ R. Pelletier,² A. Chong.¹
Cumulative Sum Analysis of the Learning Curve for Video-Assisted Minilaparotomy Donor Nephrectomy in Healthy Kidney Donors

J. Na,¹ J. Park,¹ M-.G. Yoon,¹ H. Lee,² Y. Yoon,³ K. Huh,⁴ M. Kim,⁴ S. Kim,⁴ Y. Kim,⁴ W. Han.¹
Cumulative United States Experience in Domino Liver Transplants

K. Barrera, S. Sharma, A. Gruessner, R. Gruessner.
Curative Correction of FAH Deficiency by Chimeric Stem Cells Transplantation

D. Joo,^1,2 E. Nelson,¹ Y. Zhang,¹ B. Amiot,¹ S. Ho,³ C. Lancto,⁴ D. Carlson,⁴ L. Queiroz,⁵ S. Nyberg.¹
CXCR4 Inhibition Improves Donor Leukocyte Depletion during Ex Vivo Lung Perfusion

R. Davis, Q. Gao, J. Yerxa, M. Daneshmand, J. Haney, J. Klapper, M. Hartwig, A. Barbas.
Cytokine Profiles in Children after Pediatric Kidney Transplantation with Acute and Chronic Rejection

T. Ahlenstiel-Grunow, N. Borsum, L. Pape.
Cytomegalovirus (CMV) Infection in Small Intestinal and Multivisceral Transplant Recipients: The Role of Donor Selection on CMV Incidence and Outcomes

H. Grewal, M. Czech, C. Matsumoto, M. Natarajan, J. Fraker, W. Fan, J. Timpone.
Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients and Role of Prophylaxis

G. Nance,¹ A. Serluco,¹ S. Deshpande,^2,1 R. Garro,^3,1 R. George,^3,1 M. Kelleman,³ R. Liverman.¹
Cytomegalovirus Prophylaxis Following Alemtuzumab Induction in High Risk Renal Transplant Recipients Experiencing Delayed Graft Function

S. Freedman, B. Ravichandran, B. Masters, E. Heil, K. Saharia, J. Bromberg, A. Haririan, T. Sparkes.